Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.61 |
| ▸ | CA2 | P00918 | 7/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29175682 | 0.91 | CA4 (0.56) | CA1CA2CA9CA7CA12 | |
| SCHEMBL11130505 | 0.82 | CA1 (0.52) | CA1CA2CA9CA7CA12 | |
| SCHEMBL1128202 | 0.80 | CA1 (0.65) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.78 | CA1 (1.00) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.78 | CA1 (1.00) | CA1CA2CA9CA7CA12 | |
| SCHEMBL28698839 | 0.76 | CA1 (0.58) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL29937047 | 0.75 | CA1 (0.92) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL30704776 | 0.75 | CA1 (0.92) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL28833370 | 0.72 | CA1 (0.85) | CA1CA2CA9CA7CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL11373286 | 0.72 | CA1 (0.85) | CA1CA2CA9CA7CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115058143-A | Electromagnetic wave absorbent, preparation method thereof and method for preparing wave-absorbing coating by using electromagnetic wave absorbent | 晶展(哈尔滨)科技有限责任公司 | 2022-09-16 | — | — | CN | claimed |
| CN-113200899-A | Aryl selenide compound and synthetic method thereof | 成都理工大学 | 2021-08-03 | — | — | CN | claimed |
| CN-108627654-B | Composition for eliminating interference of calcium dobesilate medicine on creatinine enzymatic detection | 武汉瀚海新酶生物科技有限公司 | 2021-03-16 | — | — | CN | claimed |
| EP-2872477-B1 | PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL | LEO LABORATORIES LTD (IE) | 2018-09-05 | — | — | EP | claimed |
| US-9624157-B2 | Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol | LEO LABORATORIES LIMITED (IE) | 2017-04-18 | — | — | US | claimed |
| US-20150329463-A1 | PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL | LEO LABORATORIES LIMITED (IE) | 2015-11-19 | — | — | US | claimed |
| EP-2872477-A1 | PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL | Leo Laboratories Limited (IE) | 2015-05-20 | — | — | EP | claimed |
| WO-2014012836-A1 | PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL | LEO LABORATORIES LIMITED (IE) | 2014-01-23 | — | — | WO | claimed |
| JP-58057372-A | — | — | None | — | — | JP | disclosed |
| CN-115058143-A | Electromagnetic wave absorbent, preparation method thereof and method for preparing wave-absorbing coating by using electromagnetic wave absorbent | 晶展(哈尔滨)科技有限责任公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-114174479-B | Lubricating oil additive and lubricating oil composition containing same | 株式会社ADEKA | 2022-08-23 | — | — | CN | disclosed |
| CN-114174480-B | Lubricating oil additive and lubricating oil composition containing same | 株式会社ADEKA | 2022-08-23 | — | — | CN | disclosed |
| CN-114174479-A | Lubricating oil additive and lubricating oil composition containing same | 株式会社ADEKA | 2022-03-11 | — | — | CN | disclosed |
| CN-114174480-A | Lubricating oil additive and lubricating oil composition containing same | 株式会社ADEKA | 2022-03-11 | — | — | CN | disclosed |
| US-6352959-B1 | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-05 | — | — | US | disclosed |
| EP-1144401-A2 | THIOCHROMANOYL CYCLOHEXENONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-17 | — | — | EP | disclosed |
| EP-1135385-A1 | THIOCHROMANOYLPYRAZOLONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000035903-A2 | THIOCHROMANOYL CYCLOHEXENONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000034270-A1 | THIOCHROMANOYLPYRAZOLONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-15 | — | — | WO | disclosed |
| JP-S5857372-A | PREPARATION OF 1,2,4-THIADIAZOLE COMPOUND, 1,2,4- THIADIAZOLINE COMPOUND OR 1,2,4-THIADIAZOLIDINE COMPOUND | NITTO CHEM IND CO LTD | 1983-04-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329463-A1 | PROCESS FOR THE PREPARATION OF INGENOL-3-ANGELATE FROM 20-DEOXY-INGENOL | TRIM25, UTP20, RARA | CA1 3933/4885CA2 3329/4885CA9 1826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.